Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Adam Eckert

Why Sunshine Biopharma Stock Is Falling Today

Sunshine Biopharma Inc (NASDAQ:SBFM) shares are trading lower following a Form424B3 filing. The company stated the filing showed the resale S3 from March 30 is now effective.

Sunshine Biopharma plans to offer on a resale basis an aggregate of 7,207,208 shares of common stock.

The stock has seen increased retail investor interest this week after the company on Tuesday announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture. 

Sunshine Biopharma is a pharmaceutical company focused on researching, developing and commercializing oncology and antiviral drugs. It was the top trending stock on Stocktwits at publication time.

See Also: Why CrowdStrike Stock Is Trading Higher

SBFM 52-Week Range: $0.04 - $9.87

According to data from Benzinga Pro, the stock was down 20.7% at $7.67 at press time.

Photo: Gam-Ol from Pixabay.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.